Cargando…

Response to: Bioactive Lipids and Coronavirus (COVID-19)-further Discussion

Detalles Bibliográficos
Autor principal:	Das, Undurti N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IMSS. Published by Elsevier Inc. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158824/ https://www.ncbi.nlm.nih.gov/pubmed/32345532 http://dx.doi.org/10.1016/j.arcmed.2020.04.004

Ejemplares similares

Bioactive Lipids in COVID-19-Further Evidence
por: Das, Undurti N.
Publicado: (2021)

Can Bioactive Lipids Inactivate Coronavirus (COVID-19)?
por: Das, Undurti N.
Publicado: (2020)

Can Bioactive Lipid Arachidonic Acid Prevent and Ameliorate COVID-19?
por: Das, Undurti N.
Publicado: (2020)

Bioactive Lipids as Mediators of the Beneficial Action(s) of Mesenchymal Stem Cells in COVID-19
por: Das, Undurti N
Publicado: (2020)

Bioactive lipid-based therapeutic approach to COVID-19 and other similar infections
por: Das, Undurti N.
Publicado: (2021)

Is There a Role for Bioactive Lipids in the Pathobiology of Diabetes Mellitus?
por: Das, Undurti N.
Publicado: (2017)

Bioactive lipids in intervertebral disc degeneration and its therapeutic implications
por: Das, Undurti N.
Publicado: (2019)

HLA-DR expression, cytokines and bioactive lipids in sepsis
por: Das, Undurti
Publicado: (2014)

Ageing: Is there a role for arachidonic acid and other bioactive lipids? A review
por: Das, Undurti N.
Publicado: (2018)

“Cell Membrane Theory of Senescence” and the Role of Bioactive Lipids in Aging, and Aging Associated Diseases and Their Therapeutic Implications
por: Das, Undurti N.
Publicado: (2021)

Beneficial role of bioactive lipids in the pathobiology, prevention, and management of HBV, HCV and alcoholic hepatitis, NAFLD, and liver cirrhosis: A review
por: Das, Undurti N.
Publicado: (2018)

Inflammatory bowel disease as a disorder of an imbalance between pro- and anti-inflammatory molecules and deficiency of resolution bioactive lipids
por: Das, Undurti N.
Publicado: (2016)

Essential fatty acids and their metabolites in the pathobiology of (coronavirus disease 2019) COVID-19
por: Das, Undurti N.
Publicado: (2021)

Further discussion on glucocorticoid treatment of COVID-19
por: Feng, Yun’ai, et al.
Publicado: (2022)

Bioactive Lipids and Coronavirus
por: Yasri, Sora, et al.
Publicado: (2020)

Can endogenous lipid molecules serve as predictors and prognostic markers of coronary heart disease?
por: Das, Undurti N
Publicado: (2008)

Potential role of dietary lipids in the prophylaxis of some clinical conditions
por: Bhagat, Urvashi, et al.
Publicado: (2015)

Oleoylethanolamide, A Bioactive Lipid Amide, as A Promising Treatment Strategy for Coronavirus/COVID-19
por: Ghaffari, Samad, et al.
Publicado: (2020)

High percentage of abnormal findings on TVU needs further discussion
por: Mourits, M J E, et al.
Publicado: (2006)

Molecular biochemical aspects of salt (sodium chloride) in inflammation and immune response with reference to hypertension and type 2 diabetes mellitus
por: Das, Undurti N.
Publicado: (2021)

Proposal for further discussion: Manpower and organization for the installation and commissioning of LIL-Systems
por: Madsen, J H B
Publicado: (1984)

Further insight into the bioactivity of the freshwater sponge Ochridaspongia rotunda
por: Talevska, Aleksandra, et al.
Publicado: (2017)

Further studies on human enteric coronaviruses
por: Caul, E. O., et al.
Publicado: (1977)

Middle East Respiratory Syndrome and Blood Donation: Topic for Further Study and Discussion
por: Wiwanitkit, Viroj
Publicado: (2014)

Conceptualization of the latent structure of autism: further evidence and discussion of dimensional and hybrid models
por: Wittkopf, Sarah, et al.
Publicado: (2022)

Continue ACE inhibitors / ARB’S till further evidence in coronavirus disease 2019 (COVID-19)
por: Bansal, Sandeep, et al.
Publicado: (2020)

The Role of Innate Immunity and Bioactive Lipid Mediators in COVID-19 and Influenza
por: Sahanic, Sabina, et al.
Publicado: (2021)

Some Further Experiments on Bimolecular Lipid Membranes
por: Hanai, T., et al.
Publicado: (1965)

Arachidonic acid and other unsaturated fatty acids and some of their metabolites function as endogenous antimicrobial molecules: A review
por: Das, Undurti N.
Publicado: (2018)

Arachidonic acid in health and disease with focus on hypertension and diabetes mellitus: A review
por: Das, Undurti N.
Publicado: (2018)

Summary and some commentaries on the discussions on Front End Computers during the week 23-27th September, 1974. Proposals for further discussions
por: Daneels, A, et al.
Publicado: (1974)

A Novel Embolization Technique to Stem Hemorrhage Complications and Cancer
por: Das, Undurti N
Publicado: (2020)

Can essential fatty acids reduce the burden of disease(s)?
por: Das, Undurti N
Publicado: (2008)

Essential fatty acids and their metabolites could function as endogenous HMG-CoA reductase and ACE enzyme inhibitors, anti-arrhythmic, anti-hypertensive, anti-atherosclerotic, anti-inflammatory, cytoprotective, and cardioprotective molecules
por: Das, Undurti N
Publicado: (2008)

Fetal Alcohol Syndrome and Essential Fatty Acids
por: Das, Undurti N
Publicado: (2006)

Lipoxins as biomarkers of lupus and other inflammatory conditions
por: Das, Undurti N
Publicado: (2011)

Current and emerging strategies for the treatment and management of systemic lupus erythematosus based on molecular signatures of acute and chronic inflammation
por: Das, Undurti N
Publicado: (2010)

A defect in Δ(6 )and Δ(5 )desaturases may be a factor in the initiation and progression of insulin resistance, the metabolic syndrome and ischemic heart disease in South Asians
por: Das, Undurti N
Publicado: (2010)

Can vagus nerve stimulation halt or ameliorate rheumatoid arthritis and lupus?
por: Das, Undurti N
Publicado: (2011)

Critical advances in septicemia and septic shock
por: Das, Undurti N
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_69b4a5cnmctm6j9blcujbmukbg